-
1
-
-
0030040395
-
The role of iron in cancer
-
E.D. Weinberg The role of iron in cancer Eur. J. Cancer Prev. 5 1996 19 36
-
(1996)
Eur. J. Cancer Prev.
, vol.5
, pp. 19-36
-
-
Weinberg, E.D.1
-
2
-
-
0034572933
-
Iron homeostasis: Insights from genetics and animal models
-
N.C. Andrews Iron homeostasis: insights from genetics and animal models Nat. Rev. Genet. 1 2000 208 217
-
(2000)
Nat. Rev. Genet.
, vol.1
, pp. 208-217
-
-
Andrews, N.C.1
-
3
-
-
0035425811
-
HFE gene and hereditary hemochromatosis: A HuGE review. Human Genome Epidemiology
-
E.H. Hanson, G. Imperatore, and W. Burke HFE gene and hereditary hemochromatosis: a HuGE review. Human Genome Epidemiology Am. J. Epidemiol. 154 2001 193 206
-
(2001)
Am. J. Epidemiol.
, vol.154
, pp. 193-206
-
-
Hanson, E.H.1
Imperatore, G.2
Burke, W.3
-
4
-
-
0029999597
-
Iron-induced tissue damage and cancer: The role of reactive oxygen species-free radicals
-
S. Okada Iron-induced tissue damage and cancer: the role of reactive oxygen species-free radicals Pathol. Int. 46 1996 311 332
-
(1996)
Pathol. Int.
, vol.46
, pp. 311-332
-
-
Okada, S.1
-
5
-
-
0014962872
-
Ribonucleotide reductase and cell proliferation. I. Variations of ribonucleotide reductase activity with tumor growth rate in a series of rat hepatomas
-
H.L. Elford, M. Freese, E. Passamani, and H.P. Morris Ribonucleotide reductase and cell proliferation. I. Variations of ribonucleotide reductase activity with tumor growth rate in a series of rat hepatomas J. Biol. Chem. 245 1970 5228 5233
-
(1970)
J. Biol. Chem.
, vol.245
, pp. 5228-5233
-
-
Elford, H.L.1
Freese, M.2
Passamani, E.3
Morris, H.P.4
-
6
-
-
0021337104
-
Iron-catalyzed hydroxyl radical formation: Stringent requirement for free iron coordination site
-
E. Graf, J.R. Mahoney, R.G. Bryant, and J.W. Eaton Iron-catalyzed hydroxyl radical formation: stringent requirement for free iron coordination site J. Biol. Chem. 259 1984 3620 3624
-
(1984)
J. Biol. Chem.
, vol.259
, pp. 3620-3624
-
-
Graf, E.1
Mahoney, J.R.2
Bryant, R.G.3
Eaton, J.W.4
-
7
-
-
84890922670
-
The role of iron and reactive oxygen species in cell death
-
S.J. Dixon, and B.R. Stockwell The role of iron and reactive oxygen species in cell death Nat. Chem. Biol. 10 2014 9 17
-
(2014)
Nat. Chem. Biol.
, vol.10
, pp. 9-17
-
-
Dixon, S.J.1
Stockwell, B.R.2
-
8
-
-
0023576896
-
Hydroxyl radical production and human DNA damage induced by ferric nitrilotriacetate and hydrogen peroxide
-
S. Inoue, and S. Kawanishi Hydroxyl radical production and human DNA damage induced by ferric nitrilotriacetate and hydrogen peroxide Cancer Res. 47 1987 6522 6527
-
(1987)
Cancer Res.
, vol.47
, pp. 6522-6527
-
-
Inoue, S.1
Kawanishi, S.2
-
9
-
-
0034626735
-
Oxidants, oxidative stress and the biology of ageing
-
T. Finkel, and N.J. Holbrook Oxidants, oxidative stress and the biology of ageing Nature 408 2000 239 247
-
(2000)
Nature
, vol.408
, pp. 239-247
-
-
Finkel, T.1
Holbrook, N.J.2
-
10
-
-
51349117161
-
Oxidative stress in the regulation of normal and neoplastic hematopoiesis
-
S. Ghaffari Oxidative stress in the regulation of normal and neoplastic hematopoiesis Antioxid. Redox Signaling 10 2008 1923 1940
-
(2008)
Antioxid. Redox Signaling
, vol.10
, pp. 1923-1940
-
-
Ghaffari, S.1
-
11
-
-
0034873185
-
Reactive oxygen species as intracellular messengers during cell growth and differentiation
-
H. Sauer, M. Wartenberg, and J. Hescheler Reactive oxygen species as intracellular messengers during cell growth and differentiation Cell. Physiol. Biochem. 11 2001 173 186
-
(2001)
Cell. Physiol. Biochem.
, vol.11
, pp. 173-186
-
-
Sauer, H.1
Wartenberg, M.2
Hescheler, J.3
-
12
-
-
34648813720
-
ROS as signalling molecules: Mechanisms that generate specificity in ROS homeostasis
-
B. D'Autreaux, and M.B. Toledano ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis Nat. Rev. Mol. Cell Biol. 8 2007 813 824
-
(2007)
Nat. Rev. Mol. Cell Biol.
, vol.8
, pp. 813-824
-
-
D'Autreaux, B.1
Toledano, M.B.2
-
13
-
-
79960427057
-
Selective killing of cancer cells by a small molecule targeting the stress response to ROS
-
L. Raj, T. Ide, A.U. Gurkar, M. Foley, M. Schenone, X. Li, N.J. Tolliday, T.R. Golub, S.A. Carr, A.F. Shamji, A.M. Stern, A. Mandinova, S.L. Schreiber, and S.W. Lee Selective killing of cancer cells by a small molecule targeting the stress response to ROS Nature 475 2011 231 234
-
(2011)
Nature
, vol.475
, pp. 231-234
-
-
Raj, L.1
Ide, T.2
Gurkar, A.U.3
Foley, M.4
Schenone, M.5
Li, X.6
Tolliday, N.J.7
Golub, T.R.8
Carr, S.A.9
Shamji, A.F.10
Stern, A.M.11
Mandinova, A.12
Schreiber, S.L.13
Lee, S.W.14
-
14
-
-
34548290810
-
Targeting ROS: Selective killing of cancer cells by a cruciferous vegetable derived pro-oxidant compound
-
X.J. Wu, and X. Hua Targeting ROS: selective killing of cancer cells by a cruciferous vegetable derived pro-oxidant compound Cancer Biol. Ther. 6 2007 646 647
-
(2007)
Cancer Biol. Ther.
, vol.6
, pp. 646-647
-
-
Wu, X.J.1
Hua, X.2
-
15
-
-
10844258104
-
Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization
-
E. Nemeth, M.S. Tuttle, J. Powelson, M.B. Vaughn, A. Donovan, D.M. Ward, T. Ganz, and J. Kaplan Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization Science 306 2004 2090 2093
-
(2004)
Science
, vol.306
, pp. 2090-2093
-
-
Nemeth, E.1
Tuttle, M.S.2
Powelson, J.3
Vaughn, M.B.4
Donovan, A.5
Ward, D.M.6
Ganz, T.7
Kaplan, J.8
-
16
-
-
0035896642
-
Hepcidin, a urinary antimicrobial peptide synthesized in the liver
-
C.H. Park, E.V. Valore, A.J. Waring, and T. Ganz Hepcidin, a urinary antimicrobial peptide synthesized in the liver J. Biol. Chem. 276 2001 7806 7810
-
(2001)
J. Biol. Chem.
, vol.276
, pp. 7806-7810
-
-
Park, C.H.1
Valore, E.V.2
Waring, A.J.3
Ganz, T.4
-
18
-
-
0032477866
-
Nramp2 is mutated in the anemic Belgrade (b) rat: Evidence of a role for Nramp2 in endosomal iron transport
-
M.D. Fleming, M.A. Romano, M.A. Su, L.M. Garrick, M.D. Garrick, and N.C. Andrews Nramp2 is mutated in the anemic Belgrade (b) rat: evidence of a role for Nramp2 in endosomal iron transport Proc. Natl. Acad. Sci. USA 95 1998 1148 1153
-
(1998)
Proc. Natl. Acad. Sci. USA
, vol.95
, pp. 1148-1153
-
-
Fleming, M.D.1
Romano, M.A.2
Su, M.A.3
Garrick, L.M.4
Garrick, M.D.5
Andrews, N.C.6
-
20
-
-
0033826764
-
Iron regulatory proteins and the molecular control of mammalian iron metabolism
-
R.S. Eisenstein Iron regulatory proteins and the molecular control of mammalian iron metabolism Annu. Rev. Nutr. 20 2000 627 662
-
(2000)
Annu. Rev. Nutr.
, vol.20
, pp. 627-662
-
-
Eisenstein, R.S.1
-
21
-
-
84876854791
-
Iron and cancer: More ore to be mined
-
S.V. Torti, and F.M. Torti Iron and cancer: more ore to be mined Nat. Rev. Cancer 13 2013 342 355
-
(2013)
Nat. Rev. Cancer
, vol.13
, pp. 342-355
-
-
Torti, S.V.1
Torti, F.M.2
-
22
-
-
67349137868
-
Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents
-
D.R. Richardson, D.S. Kalinowski, S. Lau, P.J. Jansson, and D.B. Lovejoy Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents Biochim. Biophys. Acta 1790 2009 702 717
-
(2009)
Biochim. Biophys. Acta
, vol.1790
, pp. 702-717
-
-
Richardson, D.R.1
Kalinowski, D.S.2
Lau, S.3
Jansson, P.J.4
Lovejoy, D.B.5
-
23
-
-
0031577292
-
An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements
-
K. Itoh, T. Chiba, S. Takahashi, T. Ishii, K. Igarashi, Y. Katoh, T. Oyake, N. Hayashi, K. Satoh, I. Hatayama, M. Yamamoto, and Y. Nabeshima An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements Biochem. Biophys. Res. Commun. 236 1997 313 322
-
(1997)
Biochem. Biophys. Res. Commun.
, vol.236
, pp. 313-322
-
-
Itoh, K.1
Chiba, T.2
Takahashi, S.3
Ishii, T.4
Igarashi, K.5
Katoh, Y.6
Oyake, T.7
Hayashi, N.8
Satoh, K.9
Hatayama, I.10
Yamamoto, M.11
Nabeshima, Y.12
-
24
-
-
0036371485
-
Roles of Nrf2 in activation of antioxidant enzyme genes via antioxidant responsive elements
-
T. Ishii, K. Itoh, and M. Yamamoto Roles of Nrf2 in activation of antioxidant enzyme genes via antioxidant responsive elements Methods Enzymol. 348 2002 182 190
-
(2002)
Methods Enzymol.
, vol.348
, pp. 182-190
-
-
Ishii, T.1
Itoh, K.2
Yamamoto, M.3
-
25
-
-
84867570924
-
Nrf2 inhibits hepatic iron accumulation and counteracts oxidative stress-induced liver injury in nutritional steatohepatitis
-
K. Okada, E. Warabi, H. Sugimoto, M. Horie, K. Tokushige, T. Ueda, N. Harada, K. Taguchi, E. Hashimoto, K. Itoh, T. Ishii, H. Utsunomiya, M. Yamamoto, and J. Shoda Nrf2 inhibits hepatic iron accumulation and counteracts oxidative stress-induced liver injury in nutritional steatohepatitis J. Gastroenterol. 47 2012 924 935
-
(2012)
J. Gastroenterol.
, vol.47
, pp. 924-935
-
-
Okada, K.1
Warabi, E.2
Sugimoto, H.3
Horie, M.4
Tokushige, K.5
Ueda, T.6
Harada, N.7
Taguchi, K.8
Hashimoto, E.9
Itoh, K.10
Ishii, T.11
Utsunomiya, H.12
Yamamoto, M.13
Shoda, J.14
-
26
-
-
34548825643
-
Genetic variability in iron-related oxidative stress pathways (Nrf2, NQ01, NOS3, and HO-1), iron intake, and risk of postmenopausal breast cancer
-
C.C. Hong, C.B. Ambrosone, J. Ahn, J.Y. Choi, M.L. McCullough, V.L. Stevens, C. Rodriguez, M.J. Thun, and E.E. Calle Genetic variability in iron-related oxidative stress pathways (Nrf2, NQ01, NOS3, and HO-1), iron intake, and risk of postmenopausal breast cancer Cancer Epidemiol. Biomarkers Prev 16 2007 1784 1794
-
(2007)
Cancer Epidemiol. Biomarkers Prev
, vol.16
, pp. 1784-1794
-
-
Hong, C.C.1
Ambrosone, C.B.2
Ahn, J.3
Choi, J.Y.4
McCullough, M.L.5
Stevens, V.L.6
Rodriguez, C.7
Thun, M.J.8
Calle, E.E.9
-
27
-
-
29744461403
-
Role of iron in inducing oxidative stress in thalassemia: Can it be prevented by inhibition of absorption and by antioxidants?
-
E.A. Rachmilewitz, O. Weizer-Stern, K. Adamsky, N. Amariglio, G. Rechavi, L. Breda, S. Rivella, and Z.I. Cabantchik Role of iron in inducing oxidative stress in thalassemia: can it be prevented by inhibition of absorption and by antioxidants? Ann. N. Y. Acad. Sci. 1054 2005 118 123
-
(2005)
Ann. N. Y. Acad. Sci.
, vol.1054
, pp. 118-123
-
-
Rachmilewitz, E.A.1
Weizer-Stern, O.2
Adamsky, K.3
Amariglio, N.4
Rechavi, G.5
Breda, L.6
Rivella, S.7
Cabantchik, Z.I.8
-
28
-
-
77955867065
-
Amelioration of oxidative stress in red blood cells from patients with beta-thalassemia major and intermedia and E-beta-thalassemia following administration of a fermented papaya preparation
-
E. Fibach, E.S. Tan, S. Jamuar, I. Ng, J. Amer, and E.A. Rachmilewitz Amelioration of oxidative stress in red blood cells from patients with beta-thalassemia major and intermedia and E-beta-thalassemia following administration of a fermented papaya preparation Phytother. Res. 24 2010 1334 1338
-
(2010)
Phytother. Res.
, vol.24
, pp. 1334-1338
-
-
Fibach, E.1
Tan, E.S.2
Jamuar, S.3
Ng, I.4
Amer, J.5
Rachmilewitz, E.A.6
-
29
-
-
35548981681
-
Iron-binding properties of plant phenolics and cranberry's bio-effects
-
M. Guo, C. Perez, Y. Wei, E. Rapoza, G. Su, F. Bou-Abdallah, and N.D. Chasteen Iron-binding properties of plant phenolics and cranberry's bio-effects Dalton Trans. 43 2007 4951 4961
-
(2007)
Dalton Trans.
, vol.43
, pp. 4951-4961
-
-
Guo, M.1
Perez, C.2
Wei, Y.3
Rapoza, E.4
Su, G.5
Bou-Abdallah, F.6
Chasteen, N.D.7
-
30
-
-
78650680967
-
Phenolic and carotenoid profiles of papaya fruit (Carica papaya L.) and their contents under low temperature storage
-
D.M. Rivera-Pastrana, E.M. Yahia, and G.A. Gonzalez-Aguilar Phenolic and carotenoid profiles of papaya fruit (Carica papaya L.) and their contents under low temperature storage J. Sci. Food Agric 90 2010 2358 2365
-
(2010)
J. Sci. Food Agric
, vol.90
, pp. 2358-2365
-
-
Rivera-Pastrana, D.M.1
Yahia, E.M.2
Gonzalez-Aguilar, G.A.3
-
31
-
-
84887933383
-
Depletion of a putatively druggable class of phosphatidylinositol kinases inhibits growth of p53-null tumors
-
B.M. Emerling, J.B. Hurov, G. Poulogiannis, K.S. Tsukazawa, R. Choo-Wing, G.M. Wulf, E.L. Bell, H.S. Shim, K.A. Lamia, L.E. Rameh, G. Bellinger, A.T. Sasaki, J.M. Asara, X. Yuan, A. Bullock, G.M. Denicola, J. Song, V. Brown, S. Signoretti, and L.C. Cantley Depletion of a putatively druggable class of phosphatidylinositol kinases inhibits growth of p53-null tumors Cell 155 2013 844 857
-
(2013)
Cell
, vol.155
, pp. 844-857
-
-
Emerling, B.M.1
Hurov, J.B.2
Poulogiannis, G.3
Tsukazawa, K.S.4
Choo-Wing, R.5
Wulf, G.M.6
Bell, E.L.7
Shim, H.S.8
Lamia, K.A.9
Rameh, L.E.10
Bellinger, G.11
Sasaki, A.T.12
Asara, J.M.13
Yuan, X.14
Bullock, A.15
Denicola, G.M.16
Song, J.17
Brown, V.18
Signoretti, S.19
Cantley, L.C.20
more..
-
32
-
-
33748146888
-
Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate
-
D. Trachootham, Y. Zhou, H. Zhang, Y. Demizu, Z. Chen, H. Pelicano, P.J. Chiao, G. Achanta, R.B. Arlinghaus, J. Liu, and P. Huang Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate Cancer Cell 10 2006 241 252
-
(2006)
Cancer Cell
, vol.10
, pp. 241-252
-
-
Trachootham, D.1
Zhou, Y.2
Zhang, H.3
Demizu, Y.4
Chen, Z.5
Pelicano, H.6
Chiao, P.J.7
Achanta, G.8
Arlinghaus, R.B.9
Liu, J.10
Huang, P.11
-
33
-
-
16844363378
-
The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells
-
M.L. Guzman, R.M. Rossi, L. Karnischky, X. Li, D.R. Peterson, D.S. Howard, and C.T. Jordan The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells Blood 105 2005 4163 4169
-
(2005)
Blood
, vol.105
, pp. 4163-4169
-
-
Guzman, M.L.1
Rossi, R.M.2
Karnischky, L.3
Li, X.4
Peterson, D.R.5
Howard, D.S.6
Jordan, C.T.7
-
34
-
-
84866079558
-
Oxidative stress induced by curcumin promotes the death of cutaneous T-cell lymphoma (HuT-78) by disrupting the function of several molecular targets
-
M.A. Khan, S. Gahlot, and S. Majumdar Oxidative stress induced by curcumin promotes the death of cutaneous T-cell lymphoma (HuT-78) by disrupting the function of several molecular targets Mol. Cancer Ther. 11 2012 1873 1883
-
(2012)
Mol. Cancer Ther.
, vol.11
, pp. 1873-1883
-
-
Khan, M.A.1
Gahlot, S.2
Majumdar, S.3
-
35
-
-
73349094986
-
Curcumin and cancer cells: How many ways can curry kill tumor cells selectively?
-
J. Ravindran, S. Prasad, and B.B. Aggarwal Curcumin and cancer cells: how many ways can curry kill tumor cells selectively? AAPS J. 11 2009 495 510
-
(2009)
AAPS J.
, vol.11
, pp. 495-510
-
-
Ravindran, J.1
Prasad, S.2
Aggarwal, B.B.3
-
36
-
-
58849102674
-
Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelator
-
Y. Jiao, J.t. Wilkinson, X. Di, W. Wang, H. Hatcher, N.D. Kock, R. D'Agostino Jr, M.A. Knovich, F.M. Torti, and S.V. Torti Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelator Blood 113 2009 462 469
-
(2009)
Blood
, vol.113
, pp. 462-469
-
-
Jiao, Y.1
Wilkinson, J.T.2
Di, X.3
Wang, W.4
Hatcher, H.5
Kock, N.D.6
D'Agostino, Jr.R.7
Knovich, M.A.8
Torti, F.M.9
Torti, S.V.10
-
37
-
-
0035127525
-
Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non-iron-related chronic liver disease
-
A.L. Fracanzani, D. Conte, M. Fraquelli, E. Taioli, M. Mattioli, A. Losco, and S. Fargion Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non-iron-related chronic liver disease Hepatology 33 2001 647 651
-
(2001)
Hepatology
, vol.33
, pp. 647-651
-
-
Fracanzani, A.L.1
Conte, D.2
Fraquelli, M.3
Taioli, E.4
Mattioli, M.5
Losco, A.6
Fargion, S.7
-
38
-
-
77950620367
-
HFE C282Y homozygotes are at increased risk of breast and colorectal cancer
-
N.J. Osborne, L.C. Gurrin, K.J. Allen, C.C. Constantine, M.B. Delatycki, C.E. McLaren, D.M. Gertig, G.J. Anderson, M.C. Southey, J.K. Olynyk, L.W. Powell, J.L. Hopper, G.G. Giles, and D.R. English HFE C282Y homozygotes are at increased risk of breast and colorectal cancer Hepatology 51 2010 1311 1318
-
(2010)
Hepatology
, vol.51
, pp. 1311-1318
-
-
Osborne, N.J.1
Gurrin, L.C.2
Allen, K.J.3
Constantine, C.C.4
Delatycki, M.B.5
McLaren, C.E.6
Gertig, D.M.7
Anderson, G.J.8
Southey, M.C.9
Olynyk, J.K.10
Powell, L.W.11
Hopper, J.L.12
Giles, G.G.13
English, D.R.14
-
39
-
-
9144224804
-
Hepatocellular carcinoma in the thalassaemia syndromes
-
C. Borgna-Pignatti, G. Vergine, T. Lombardo, M.D. Cappellini, P. Cianciulli, A. Maggio, D. Renda, M.E. Lai, A. Mandas, G. Forni, A. Piga, and M.G. Bisconte Hepatocellular carcinoma in the thalassaemia syndromes Br. J. Haematol. 124 2004 114 117
-
(2004)
Br. J. Haematol.
, vol.124
, pp. 114-117
-
-
Borgna-Pignatti, C.1
Vergine, G.2
Lombardo, T.3
Cappellini, M.D.4
Cianciulli, P.5
Maggio, A.6
Renda, D.7
Lai, M.E.8
Mandas, A.9
Forni, G.10
Piga, A.11
Bisconte, M.G.12
-
40
-
-
84876284207
-
Hepatocellular carcinoma in hepatitis-negative patients with thalassemia intermedia: A closer look at the role of siderosis
-
J.E. Maakaron, M.D. Cappellini, G. Graziadei, J.B. Ayache, and A.T. Taher Hepatocellular carcinoma in hepatitis-negative patients with thalassemia intermedia: a closer look at the role of siderosis Ann. Hepatol. 12 2013 142 146
-
(2013)
Ann. Hepatol.
, vol.12
, pp. 142-146
-
-
Maakaron, J.E.1
Cappellini, M.D.2
Graziadei, G.3
Ayache, J.B.4
Taher, A.T.5
-
41
-
-
80054838641
-
Beta-Thalassemia: A model for elucidating the dynamic regulation of ineffective erythropoiesis and iron metabolism
-
Y. Ginzburg, and S. Rivella beta-Thalassemia: a model for elucidating the dynamic regulation of ineffective erythropoiesis and iron metabolism Blood 118 2011 4321 4330
-
(2011)
Blood
, vol.118
, pp. 4321-4330
-
-
Ginzburg, Y.1
Rivella, S.2
-
42
-
-
78649813036
-
Hepcidin as a therapeutic tool to limit iron overload and improve anemia in beta-thalassemic mice
-
S. Gardenghi, P. Ramos, M.F. Marongiu, L. Melchiori, L. Breda, E. Guy, K. Muirhead, N. Rao, C.N. Roy, N.C. Andrews, E. Nemeth, A. Follenzi, X. An, N. Mohandas, Y. Ginzburg, E.A. Rachmilewitz, P.J. Giardina, R.W. Grady, and S. Rivella Hepcidin as a therapeutic tool to limit iron overload and improve anemia in beta-thalassemic mice J. Clin. Invest. 120 2010 4466 4477
-
(2010)
J. Clin. Invest.
, vol.120
, pp. 4466-4477
-
-
Gardenghi, S.1
Ramos, P.2
Marongiu, M.F.3
Melchiori, L.4
Breda, L.5
Guy, E.6
Muirhead, K.7
Rao, N.8
Roy, C.N.9
Andrews, N.C.10
Nemeth, E.11
Follenzi, A.12
An, X.13
Mohandas, N.14
Ginzburg, Y.15
Rachmilewitz, E.A.16
Giardina, P.J.17
Grady, R.W.18
Rivella, S.19
-
43
-
-
84055190801
-
Minihepcidins are rationally designed small peptides that mimic hepcidin activity in mice and may be useful for the treatment of iron overload
-
G.C. Preza, P. Ruchala, R. Pinon, E. Ramos, B. Qiao, M.A. Peralta, S. Sharma, A. Waring, T. Ganz, and E. Nemeth Minihepcidins are rationally designed small peptides that mimic hepcidin activity in mice and may be useful for the treatment of iron overload J. Clin. Invest. 121 2011 4880 4888
-
(2011)
J. Clin. Invest.
, vol.121
, pp. 4880-4888
-
-
Preza, G.C.1
Ruchala, P.2
Pinon, R.3
Ramos, E.4
Qiao, B.5
Peralta, M.A.6
Sharma, S.7
Waring, A.8
Ganz, T.9
Nemeth, E.10
-
44
-
-
84875849962
-
Reducing TMPRSS6 ameliorates hemochromatosis and beta-thalassemia in mice
-
S. Guo, C. Casu, S. Gardenghi, S. Booten, M. Aghajan, R. Peralta, A. Watt, S. Freier, B.P. Monia, and S. Rivella Reducing TMPRSS6 ameliorates hemochromatosis and beta-thalassemia in mice J. Clin. Invest. 123 2013 1531 1541
-
(2013)
J. Clin. Invest.
, vol.123
, pp. 1531-1541
-
-
Guo, S.1
Casu, C.2
Gardenghi, S.3
Booten, S.4
Aghajan, M.5
Peralta, R.6
Watt, A.7
Freier, S.8
Monia, B.P.9
Rivella, S.10
-
45
-
-
47649090354
-
Decreased cancer risk after iron reduction in patients with peripheral arterial disease: Results from a randomized trial
-
L.R. Zacharski, B.K. Chow, P.S. Howes, G. Shamayeva, J.A. Baron, R.L. Dalman, D.J. Malenka, C.K. Ozaki, and P.W. Lavori Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trial J. Natl. Cancer Inst. 100 2008 996 1002
-
(2008)
J. Natl. Cancer Inst.
, vol.100
, pp. 996-1002
-
-
Zacharski, L.R.1
Chow, B.K.2
Howes, P.S.3
Shamayeva, G.4
Baron, J.A.5
Dalman, R.L.6
Malenka, D.J.7
Ozaki, C.K.8
Lavori, P.W.9
-
46
-
-
32144431895
-
Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: A basis for clinical decision making
-
L. Malcovati, M.G. Porta, C. Pascutto, R. Invernizzi, M. Boni, E. Travaglino, F. Passamonti, L. Arcaini, M. Maffioli, P. Bernasconi, M. Lazzarino, and M. Cazzola Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making J. Clin. Oncol. 23 2005 7594 7603
-
(2005)
J. Clin. Oncol.
, vol.23
, pp. 7594-7603
-
-
Malcovati, L.1
Porta, M.G.2
Pascutto, C.3
Invernizzi, R.4
Boni, M.5
Travaglino, E.6
Passamonti, F.7
Arcaini, L.8
Maffioli, M.9
Bernasconi, P.10
Lazzarino, M.11
Cazzola, M.12
-
47
-
-
84892543077
-
Comparison of 24-month outcomes in chelated and non-chelated lower-risk patients with myelodysplastic syndromes in a prospective registry
-
R.M. Lyons, B.J. Marek, C. Paley, J. Esposito, L. Garbo, N. Dibella, and G. Garcia-Manero Comparison of 24-month outcomes in chelated and non-chelated lower-risk patients with myelodysplastic syndromes in a prospective registry Leuk. Res. 38 2013 149 154
-
(2013)
Leuk. Res.
, vol.38
, pp. 149-154
-
-
Lyons, R.M.1
Marek, B.J.2
Paley, C.3
Esposito, J.4
Garbo, L.5
Dibella, N.6
Garcia-Manero, G.7
-
48
-
-
77953441332
-
Red blood cell transfusion independence following the initiation of iron chelation therapy in myelodysplastic syndrome
-
M.A. Badawi, L.M. Vickars, J.M. Chase, and H.A. Leitch Red blood cell transfusion independence following the initiation of iron chelation therapy in myelodysplastic syndrome Adv. Hematol. 2010 2010 164045
-
(2010)
Adv. Hematol.
, vol.2010
, pp. 164045
-
-
Badawi, M.A.1
Vickars, L.M.2
Chase, J.M.3
Leitch, H.A.4
-
49
-
-
84862529448
-
Deferasirox exposure induces reactive oxygen species and reduces growth and viability of myelodysplastic hematopoietic progenitors
-
V. Pullarkat, A. Sehgal, L. Li, Z. Meng, A. Lin, S. Forman, and R. Bhatia Deferasirox exposure induces reactive oxygen species and reduces growth and viability of myelodysplastic hematopoietic progenitors Leuk. Res. 36 2012 966 973
-
(2012)
Leuk. Res.
, vol.36
, pp. 966-973
-
-
Pullarkat, V.1
Sehgal, A.2
Li, L.3
Meng, Z.4
Lin, A.5
Forman, S.6
Bhatia, R.7
-
50
-
-
84862527496
-
Selective toxicity towards myelodysplastic hematopoietic progenitors - Another rationale for iron chelation in MDS
-
E. Fibach, and E.A. Rachmilewitz Selective toxicity towards myelodysplastic hematopoietic progenitors - another rationale for iron chelation in MDS Leuk. Res. 36 2012 962 963
-
(2012)
Leuk. Res.
, vol.36
, pp. 962-963
-
-
Fibach, E.1
Rachmilewitz, E.A.2
-
51
-
-
0036270885
-
Dietary iron supplementation enhances DSS-induced colitis and associated colorectal carcinoma development in mice
-
D.N. Seril, J. Liao, K.L. Ho, A. Warsi, C.S. Yang, and G.Y. Yang Dietary iron supplementation enhances DSS-induced colitis and associated colorectal carcinoma development in mice Dig. Dis. Sci. 47 2002 1266 1278
-
(2002)
Dig. Dis. Sci.
, vol.47
, pp. 1266-1278
-
-
Seril, D.N.1
Liao, J.2
Ho, K.L.3
Warsi, A.4
Yang, C.S.5
Yang, G.Y.6
-
52
-
-
47849099083
-
Does iron have a role in breast cancer?
-
X. Huang Does iron have a role in breast cancer? Lancet Oncol. 9 2008 803 807
-
(2008)
Lancet Oncol.
, vol.9
, pp. 803-807
-
-
Huang, X.1
-
53
-
-
84879229020
-
A link between premenopausal iron deficiency and breast cancer malignancy
-
J. Jian, Q. Yang, Y. Shao, D. Axelrod, J. Smith, B. Singh, S. Krauter, L. Chiriboga, Z. Yang, J. Li, and X. Huang A link between premenopausal iron deficiency and breast cancer malignancy BMC Cancer 13 2013 307
-
(2013)
BMC Cancer
, vol.13
, pp. 307
-
-
Jian, J.1
Yang, Q.2
Shao, Y.3
Axelrod, D.4
Smith, J.5
Singh, B.6
Krauter, S.7
Chiriboga, L.8
Yang, Z.9
Li, J.10
Huang, X.11
-
54
-
-
84879334969
-
Ferritin stimulates breast cancer cells through an iron-independent mechanism and is localized within tumor-associated macrophages
-
A.A. Alkhateeb, B. Han, and J.R. Connor Ferritin stimulates breast cancer cells through an iron-independent mechanism and is localized within tumor-associated macrophages Breast Cancer Res. Treat. 137 2013 733 744
-
(2013)
Breast Cancer Res. Treat.
, vol.137
, pp. 733-744
-
-
Alkhateeb, A.A.1
Han, B.2
Connor, J.R.3
-
55
-
-
35349008009
-
Iron accumulation in mammary tumor suggests a tug of war between tumor and host for the microelement
-
I. Freitas, E. Boncompagni, R. Vaccarone, C. Fenoglio, S. Barni, and G.F. Baronzio Iron accumulation in mammary tumor suggests a tug of war between tumor and host for the microelement Anticancer Res. 27 2007 3059 3065
-
(2007)
Anticancer Res.
, vol.27
, pp. 3059-3065
-
-
Freitas, I.1
Boncompagni, E.2
Vaccarone, R.3
Fenoglio, C.4
Barni, S.5
Baronzio, G.F.6
-
56
-
-
77955607931
-
Ferroportin and iron regulation in breast cancer progression and prognosis
-
Z.K. Pinnix, L.D. Miller, W. Wang, R. D'Agostino Jr, T. Kute, M.C. Willingham, H. Hatcher, L. Tesfay, G. Sui, X. Di, S.V. Torti, and F.M. Torti Ferroportin and iron regulation in breast cancer progression and prognosis Sci. Transl. Med. 2 2010 43ra56
-
(2010)
Sci. Transl. Med.
, vol.2
, pp. 43ra56
-
-
Pinnix, Z.K.1
Miller, L.D.2
Wang, W.3
D'Agostino, Jr.R.4
Kute, T.5
Willingham, M.C.6
Hatcher, H.7
Tesfay, L.8
Sui, G.9
Di, X.10
Torti, S.V.11
Torti, F.M.12
-
57
-
-
74849109475
-
Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen
-
H.O. Habashy, D.G. Powe, C.M. Staka, E.A. Rakha, G. Ball, A.R. Green, M. Aleskandarany, E.C. Paish, R.D. Macmillan, R.I. Nicholson, I.O. Ellis, and J.M. Gee Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen Breast Cancer Res. Treat. 119 2010 283 293
-
(2010)
Breast Cancer Res. Treat.
, vol.119
, pp. 283-293
-
-
Habashy, H.O.1
Powe, D.G.2
Staka, C.M.3
Rakha, E.A.4
Ball, G.5
Green, A.R.6
Aleskandarany, M.7
Paish, E.C.8
Macmillan, R.D.9
Nicholson, R.I.10
Ellis, I.O.11
Gee, J.M.12
-
58
-
-
8444235919
-
Potent antitumor activity of novel iron chelators derived from di-2-pyridylketone isonicotinoyl hydrazone involves Fenton-derived free radical generation
-
T.B. Chaston, R.N. Watts, J. Yuan, and D.R. Richardson Potent antitumor activity of novel iron chelators derived from di-2-pyridylketone isonicotinoyl hydrazone involves Fenton-derived free radical generation Clin. Cancer Res. 10 2004 7365 7374
-
(2004)
Clin. Cancer Res.
, vol.10
, pp. 7365-7374
-
-
Chaston, T.B.1
Watts, R.N.2
Yuan, J.3
Richardson, D.R.4
-
59
-
-
34250778335
-
Future of toxicology - Iron chelators and differing modes of action and toxicity: The changing face of iron chelation therapy
-
D.S. Kalinowski, and D.R. Richardson Future of toxicology - iron chelators and differing modes of action and toxicity: the changing face of iron chelation therapy Chem. Res. Toxicol. 20 2007 715 720
-
(2007)
Chem. Res. Toxicol.
, vol.20
, pp. 715-720
-
-
Kalinowski, D.S.1
Richardson, D.R.2
-
60
-
-
84883200039
-
Hemochromatosis enhances tumor progression via upregulation of intracellular iron in head and neck cancer
-
M. Lenarduzzi, A.B. Hui, S. Yue, E. Ito, W. Shi, J. Williams, J. Bruce, N. Sakemura-Nakatsugawa, W. Xu, A. Schimmer, and F.F. Liu Hemochromatosis enhances tumor progression via upregulation of intracellular iron in head and neck cancer PLoS One 8 2013 e74075
-
(2013)
PLoS One
, vol.8
, pp. e74075
-
-
Lenarduzzi, M.1
Hui, A.B.2
Yue, S.3
Ito, E.4
Shi, W.5
Williams, J.6
Bruce, J.7
Sakemura-Nakatsugawa, N.8
Xu, W.9
Schimmer, A.10
Liu, F.F.11
-
61
-
-
84876009407
-
Modulation of intracellular iron metabolism by iron chelation affects chromatin remodeling proteins and corresponding epigenetic modifications in breast cancer cells and increases their sensitivity to chemotherapeutic agents
-
I.P. Pogribny, V.P. Tryndyak, M. Pogribna, S. Shpyleva, G. Surratt, G. Gamboa da Costa, and F.A. Beland Modulation of intracellular iron metabolism by iron chelation affects chromatin remodeling proteins and corresponding epigenetic modifications in breast cancer cells and increases their sensitivity to chemotherapeutic agents Int. J. Oncol. 42 2013 1822 1832
-
(2013)
Int. J. Oncol.
, vol.42
, pp. 1822-1832
-
-
Pogribny, I.P.1
Tryndyak, V.P.2
Pogribna, M.3
Shpyleva, S.4
Surratt, G.5
Gamboa Da Costa, G.6
Beland, F.A.7
-
62
-
-
84880834280
-
Iron deprivation in cancer - Potential therapeutic implications
-
J.L. Heath, J.M. Weiss, C.P. Lavau, and D.S. Wechsler Iron deprivation in cancer - potential therapeutic implications Nutrients 5 2013 2836 2859
-
(2013)
Nutrients
, vol.5
, pp. 2836-2859
-
-
Heath, J.L.1
Weiss, J.M.2
Lavau, C.P.3
Wechsler, D.S.4
-
63
-
-
77951046942
-
Targeting iron homeostasis induces cellular differentiation and synergizes with differentiating agents in acute myeloid leukemia
-
C. Callens, S. Coulon, J. Naudin, I. Radford-Weiss, N. Boissel, E. Raffoux, P.H. Wang, S. Agarwal, H. Tamouza, E. Paubelle, V. Asnafi, J.A. Ribeil, P. Dessen, D. Canioni, O. Chandesris, M.T. Rubio, C. Beaumont, M. Benhamou, H. Dombret, E. Macintyre, R.C. Monteiro, I.C. Moura, and O. Hermine Targeting iron homeostasis induces cellular differentiation and synergizes with differentiating agents in acute myeloid leukemia J. Exp. Med. 207 2010 731 750
-
(2010)
J. Exp. Med.
, vol.207
, pp. 731-750
-
-
Callens, C.1
Coulon, S.2
Naudin, J.3
Radford-Weiss, I.4
Boissel, N.5
Raffoux, E.6
Wang, P.H.7
Agarwal, S.8
Tamouza, H.9
Paubelle, E.10
Asnafi, V.11
Ribeil, J.A.12
Dessen, P.13
Canioni, D.14
Chandesris, O.15
Rubio, M.T.16
Beaumont, C.17
Benhamou, M.18
Dombret, H.19
Macintyre, E.20
Monteiro, R.C.21
Moura, I.C.22
Hermine, O.23
more..
-
64
-
-
81255203710
-
The oral iron chelator deferasirox induces apoptosis in myeloid leukemia cells by targeting caspase
-
J.L. Kim, H.N. Kang, M.H. Kang, Y.A. Yoo, J.S. Kim, and C.W. Choi The oral iron chelator deferasirox induces apoptosis in myeloid leukemia cells by targeting caspase Acta Haematol. 126 2011 241 245
-
(2011)
Acta Haematol.
, vol.126
, pp. 241-245
-
-
Kim, J.L.1
Kang, H.N.2
Kang, M.H.3
Yoo, Y.A.4
Kim, J.S.5
Choi, C.W.6
-
65
-
-
79958124637
-
Iron chelation therapy with deferasirox induced complete remission in a patient with chemotherapy-resistant acute monocytic leukemia
-
T. Fukushima, H. Kawabata, T. Nakamura, H. Iwao, A. Nakajima, M. Miki, T. Sakai, T. Sawaki, Y. Fujita, M. Tanaka, Y. Masaki, Y. Hirose, and H. Umehara Iron chelation therapy with deferasirox induced complete remission in a patient with chemotherapy-resistant acute monocytic leukemia Anticancer Res. 31 2011 1741 1744
-
(2011)
Anticancer Res.
, vol.31
, pp. 1741-1744
-
-
Fukushima, T.1
Kawabata, H.2
Nakamura, T.3
Iwao, H.4
Nakajima, A.5
Miki, M.6
Sakai, T.7
Sawaki, T.8
Fujita, Y.9
Tanaka, M.10
Masaki, Y.11
Hirose, Y.12
Umehara, H.13
-
66
-
-
0023135326
-
In vitro and in vivo effects of deferoxamine in neonatal acute leukemia
-
Z. Estrov, A. Tawa, X.H. Wang, I.D. Dube, H. Sulh, A. Cohen, E.W. Gelfand, and M.H. Freedman in vitro and in vivo effects of deferoxamine in neonatal acute leukemia Blood 69 1987 757 761
-
(1987)
Blood
, vol.69
, pp. 757-761
-
-
Estrov, Z.1
Tawa, A.2
Wang, X.H.3
Dube, I.D.4
Sulh, H.5
Cohen, A.6
Gelfand, E.W.7
Freedman, M.H.8
-
67
-
-
33744526999
-
Triapine and cytarabine is an active combination in patients with acute leukemia or myelodysplastic syndrome
-
K.W. Yee, J. Cortes, A. Ferrajoli, G. Garcia-Manero, S. Verstovsek, W. Wierda, D. Thomas, S. Faderl, I. King, S.M. O'Brien, S. Jeha, M. Andreeff, A. Cahill, M. Sznol, and F.J. Giles Triapine and cytarabine is an active combination in patients with acute leukemia or myelodysplastic syndrome Leuk. Res. 30 2006 813 822
-
(2006)
Leuk. Res.
, vol.30
, pp. 813-822
-
-
Yee, K.W.1
Cortes, J.2
Ferrajoli, A.3
Garcia-Manero, G.4
Verstovsek, S.5
Wierda, W.6
Thomas, D.7
Faderl, S.8
King, I.9
O'Brien, S.M.10
Jeha, S.11
Andreeff, M.12
Cahill, A.13
Sznol, M.14
Giles, F.J.15
-
68
-
-
84897399513
-
Oral ciclopirox olamine displays biological activity in a phase i study in patients with advanced hematologic malignancies
-
M.D. Minden, D.E. Hogge, S.J. Weir, J. Kasper, D.A. Webster, L. Patton, Y. Jitkova, R. Hurren, M. Gronda, C.A. Goard, L.G. Rajewski, J.L. Haslam, K.E. Heppert, K. Schorno, H. Chang, J.M. Brandwein, V. Gupta, A.C. Schuh, S. Trudel, K.W. Yee, G.A. Reed, and A.D. Schimmer Oral ciclopirox olamine displays biological activity in a phase I study in patients with advanced hematologic malignancies Am. J. Hematol. 89 2014 363 368
-
(2014)
Am. J. Hematol.
, vol.89
, pp. 363-368
-
-
Minden, M.D.1
Hogge, D.E.2
Weir, S.J.3
Kasper, J.4
Webster, D.A.5
Patton, L.6
Jitkova, Y.7
Hurren, R.8
Gronda, M.9
Goard, C.A.10
Rajewski, L.G.11
Haslam, J.L.12
Heppert, K.E.13
Schorno, K.14
Chang, H.15
Brandwein, J.M.16
Gupta, V.17
Schuh, A.C.18
Trudel, S.19
Yee, K.W.20
Reed, G.A.21
Schimmer, A.D.22
more..
-
69
-
-
0025126032
-
Effects of a single course of deferoxamine in neuroblastoma patients
-
A. Donfrancesco, G. Deb, C. Dominici, D. Pileggi, M.A. Castello, and L. Helson Effects of a single course of deferoxamine in neuroblastoma patients Cancer Res. 50 1990 4929 4930
-
(1990)
Cancer Res.
, vol.50
, pp. 4929-4930
-
-
Donfrancesco, A.1
Deb, G.2
Dominici, C.3
Pileggi, D.4
Castello, M.A.5
Helson, L.6
-
70
-
-
79651473123
-
The iron-chelating drug triapine causes pronounced mitochondrial thiol redox stress
-
J.M. Myers, W.E. Antholine, J. Zielonka, and C.R. Myers The iron-chelating drug triapine causes pronounced mitochondrial thiol redox stress Toxicol. Lett. 201 2011 130 136
-
(2011)
Toxicol. Lett.
, vol.201
, pp. 130-136
-
-
Myers, J.M.1
Antholine, W.E.2
Zielonka, J.3
Myers, C.R.4
-
71
-
-
70449466605
-
Chelation of intracellular iron with the antifungal agent ciclopirox olamine induces cell death in leukemia and myeloma cells
-
Y. Eberhard, S.P. McDermott, X. Wang, M. Gronda, A. Venugopal, T.E. Wood, R. Hurren, A. Datti, R.A. Batey, J. Wrana, W.E. Antholine, J.E. Dick, and A.D. Schimmer Chelation of intracellular iron with the antifungal agent ciclopirox olamine induces cell death in leukemia and myeloma cells Blood 114 2009 3064 3073
-
(2009)
Blood
, vol.114
, pp. 3064-3073
-
-
Eberhard, Y.1
McDermott, S.P.2
Wang, X.3
Gronda, M.4
Venugopal, A.5
Wood, T.E.6
Hurren, R.7
Datti, A.8
Batey, R.A.9
Wrana, J.10
Antholine, W.E.11
Dick, J.E.12
Schimmer, A.D.13
-
72
-
-
80052243548
-
Rescuing iron-overloaded macrophages by conservative relocation of the accumulated metal
-
Y.S. Sohn, A.M. Mitterstiller, W. Breuer, G. Weiss, and Z.I. Cabantchik Rescuing iron-overloaded macrophages by conservative relocation of the accumulated metal Br. J. Pharmacol. 164 2011 406 418
-
(2011)
Br. J. Pharmacol.
, vol.164
, pp. 406-418
-
-
Sohn, Y.S.1
Mitterstiller, A.M.2
Breuer, W.3
Weiss, G.4
Cabantchik, Z.I.5
|